🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Over the years, Drug-Coated Balloons 🎈 (DCBs) have undergone extensive development to meet the challenges of minimizing restenosis and maintaining vessel patency. With this new special report on The Essentials of DCB, led by ABaumbach , we aim to enhance understanding of

‼️#EAPCI Membership BENEFITS‼️ 👥 Savings on #EuroPCR & #PCRLV ⏭ #EAPCI webinars on #ESC365 🏆 #EAPCI Training Grants 📚 EuroIntervention #EAPCI Journal Club 📚 Savings on PCR-EAPCI textbooks 🎓 Savings on #EAPCI courses & certification exams and MORE…. 🔥 JOIN US TODAY 👉

#EAPCIJournalClub Season 2025 🎙️ASK YOUR QUESTION to the #EAPCIJournalClub Team in comments to this post ‼️Top 3 questions will be asked first in the #EAPCIJournalClub‼️ 📚#OCCUPI trial 🗓️6 January 2025 ⏰18:00-19:00 Register for FREE at #ESC365 🔗bit.ly/EAPCIJC-OCCUPI

🫀#EAPCI Journal Club 🫀 📚#OCCUPI trial ⁉️OCT-guided 🆚 Angio-guided PCI for patients w/ complex lesions 🗓️6 January 2025 ⏰18:00 CET 🪢REGISTER NOW for FREE at #ESC365 🔗bit.ly/EAPCIJC-OCCUPI Tom Johnson Erik Rafflenbeul Pawel Gasior Prof. Sung-Jin Hong

🟣 #EuroPCR Submission 🚨🚨🚨 ⌛️Deadline 👉 12 January - 23:59 (CET) 📮SUBMIT NOW 👉 bit.ly/3BTpawp 🎯Late-Breaking Trials 🎯Scientific Abstracts 🎯Clinical Cases 🎯Images 🎯Innovations PCRonline 🫀 DrThomasCuisset nicolas dumonteil Nieves Gonzalo Tom Johnson MIЯVΛƬ #IC

that's not enough squares

The PEERLESS trial compares 2️⃣ catheter-based interventions for intermediate-risk PE, w/ the 🔎 supporting the use of large-bore mechanical thrombectomy over catheter-directed thrombolytics when evaluated using a win ratio of hierarchical endpoints. bit.ly/4g8oFwr

😱😧

LCX #CTO G2 punctured failed→Conq 12 punctured→#HDR→IP??→XT nontip→2nd HDR→EP stains→sionblack failed→#KWT→#TDHDR→Sionblack went to EP from IP→G1retouting using #TD　→ TL get. Watch how I manipulated GW to keep GW in IP and prevent that GW go out to EP.

Abelacimab versus Rivaroxaban in Patients with Atrial Fibrillation | New England Journal of Medicine nejm.org/doi/full/10.10… Asundexian also lowered bleeding events...

Bifurcation PCI with 2 stents and without imaging should be forbidden.

𝐌𝐕𝐏! 🌟 𝐌𝐕𝐏! 🌟 𝐌𝐕𝐏! 🌟

Could Titanium-nitride-oxide-coated stent be a game-changer in #ACS management? A patient-level meta-analysis compares Titanium-Nitride-Oxide-coated stents vs. Drug-Eluting Stents in ACS patients. Read more in #EHJ. doi.org/10.1093/eurhea… #cardiotwitter European Society of Cardiology Journals European Society of Cardiology

💻 How should I treat ostial left circumflex stenosis? Free PCR Webinar! Join coordinator Goran Stankovic, MD, PhD with @burzotta_f, Fahim H. Jafary and Maciej Lesiak on Monday 3 March 2025 at 3:00pm (UTC+1). Learn to assess left main 0,0,1 bifurcation lesions, understand treatment strategies and

CT guided PCI Planning in #P4 🎯 Ostial RCA with thick, circumferential calcium (HU > 1.5k). Plan: 🎬 AL 0.75 guiding for anterior take off ♟️IVL ostial RCA 📏 Stent 32 mm to cover the complete plaque jcspratt Yader Sandoval Emmanouil Brilakis PCRonline 🫀 Ziad Ali TCTMD

Here’s my guide to navigate the #ACC25 trials, coming this weekend and featured in many journals with a (very) high impact factor. 1. WARRIOR = Intensive medical therapy in women with ANOCA/INOCA 2. STRIDE = Semaglutide in type 2 diabetes and peripheral artery disease 3. API-CAT

Et d'avoir IVUS+OCT dans #cathlab

A few points on where we are with Factor XI inhibitors in atrial fibrillation: 1) No evidence of efficacy for thrombotic events has been demonstrated to date 2) The OCEANIC-AF trial indicated a reduction in bleeding with asundexian compared to apixaban. However, the trial has

🚨#EAPCI Webinar Alert 🚨 🎯 Management of obese patients with and without diabetes in ACS - acute and in-hospital care chief Mamas A. Mamas Valeria Paradies #DrKoskinas 🗓️ 13 May 2025 - 18:00 CET 👉 Free registration: esc365.escardio.org/event/2001